These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


790 related items for PubMed ID: 21470172

  • 1. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.
    Kratochwil NA, Gatti-McArthur S, Hoener MC, Lindemann L, Christ AD, Green LG, Guba W, Martin RE, Malherbe P, Porter RH, Slack JP, Winnig M, Dehmlow H, Grether U, Hertel C, Narquizian R, Panousis CG, Kolczewski S, Steward L.
    Curr Top Med Chem; 2011; 11(15):1902-24. PubMed ID: 21470172
    [Abstract] [Full Text] [Related]

  • 2. An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application.
    Kratochwil NA, Malherbe P, Lindemann L, Ebeling M, Hoener MC, Mühlemann A, Porter RH, Stahl M, Gerber PR.
    J Chem Inf Model; 2005; 45(5):1324-36. PubMed ID: 16180909
    [Abstract] [Full Text] [Related]

  • 3. Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios.
    Di Pizio A, Levit A, Slutzki M, Behrens M, Karaman R, Niv MY.
    Methods Cell Biol; 2016; 132():401-27. PubMed ID: 26928553
    [Abstract] [Full Text] [Related]

  • 4. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T, Giegerich C, Evers A.
    J Med Chem; 2009 May 14; 52(9):2923-32. PubMed ID: 19374402
    [Abstract] [Full Text] [Related]

  • 5. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J, Kling RC, Gmeiner P, Löber S.
    Bioorg Med Chem; 2015 Jul 15; 23(14):3880-906. PubMed ID: 25638496
    [Abstract] [Full Text] [Related]

  • 6. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?
    Vass M, Kooistra AJ, Verhoeven S, Gloriam D, de Esch IJP, de Graaf C.
    Methods Mol Biol; 2018 Jul 15; 1705():73-113. PubMed ID: 29188559
    [Abstract] [Full Text] [Related]

  • 7. Molecular interaction fingerprint approaches for GPCR drug discovery.
    Vass M, Kooistra AJ, Ritschel T, Leurs R, de Esch IJ, de Graaf C.
    Curr Opin Pharmacol; 2016 Oct 15; 30():59-68. PubMed ID: 27479316
    [Abstract] [Full Text] [Related]

  • 8. Improving the Modeling of Extracellular Ligand Binding Pockets in RosettaGPCR for Conformational Selection.
    Liessmann F, Künze G, Meiler J.
    Int J Mol Sci; 2023 Apr 24; 24(9):. PubMed ID: 37175495
    [Abstract] [Full Text] [Related]

  • 9. GPCR Homology Model Generation for Lead Optimization.
    Tautermann CS.
    Methods Mol Biol; 2018 Apr 24; 1705():115-131. PubMed ID: 29188560
    [Abstract] [Full Text] [Related]

  • 10. Characterizing common substructures of ligands for GPCR protein subfamilies.
    Erguner B, Hattori M, Goto S, Kanehisa M.
    Genome Inform; 2010 Apr 24; 24():31-41. PubMed ID: 22081587
    [Abstract] [Full Text] [Related]

  • 11. Pharmacophore-Map-Pick: A Method to Generate Pharmacophore Models for All Human GPCRs.
    Dai SX, Li GH, Gao YD, Huang JF.
    Mol Inform; 2016 Feb 24; 35(2):81-91. PubMed ID: 27491793
    [Abstract] [Full Text] [Related]

  • 12. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
    Kooistra AJ, Kuhne S, de Esch IJ, Leurs R, de Graaf C.
    Br J Pharmacol; 2013 Sep 24; 170(1):101-26. PubMed ID: 23713847
    [Abstract] [Full Text] [Related]

  • 13. 7TM Domain Structure of Adhesion GPCRs.
    de Graaf C, Nijmeijer S, Wolf S, Ernst OP.
    Handb Exp Pharmacol; 2016 Sep 24; 234():43-66. PubMed ID: 27832483
    [Abstract] [Full Text] [Related]

  • 14. Snooker: a structure-based pharmacophore generation tool applied to class A GPCRs.
    Sanders MP, Verhoeven S, de Graaf C, Roumen L, Vroling B, Nabuurs SB, de Vlieg J, Klomp JP.
    J Chem Inf Model; 2011 Sep 26; 51(9):2277-92. PubMed ID: 21866955
    [Abstract] [Full Text] [Related]

  • 15. Drug design of GPCR ligands using physicogenetics and chemogenomics--principles and case studies.
    Frimurer TM, Högberg T.
    Curr Top Med Chem; 2011 Sep 26; 11(15):1882-901. PubMed ID: 21470174
    [Abstract] [Full Text] [Related]

  • 16. Beyond the Ligand: Extracellular and Transcellular G Protein-Coupled Receptor Complexes in Physiology and Pharmacology.
    Dunn HA, Orlandi C, Martemyanov KA.
    Pharmacol Rev; 2019 Oct 26; 71(4):503-519. PubMed ID: 31515243
    [Abstract] [Full Text] [Related]

  • 17. Structures of G protein-coupled receptors reveal new opportunities for drug discovery.
    Cooke RM, Brown AJ, Marshall FH, Mason JS.
    Drug Discov Today; 2015 Nov 26; 20(11):1355-64. PubMed ID: 26303408
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M, Bender E, Schamberger J, Eitner F.
    Int J Mol Sci; 2021 Feb 10; 22(4):. PubMed ID: 33578942
    [Abstract] [Full Text] [Related]

  • 19. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T, Simms J, Christopoulos A, Wootten D, Sexton PM.
    PLoS Comput Biol; 2017 Nov 10; 13(11):e1005819. PubMed ID: 29131821
    [Abstract] [Full Text] [Related]

  • 20. Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications.
    Cvicek V, Goddard WA, Abrol R.
    PLoS Comput Biol; 2016 Mar 10; 12(3):e1004805. PubMed ID: 27028541
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.